456 related articles for article (PubMed ID: 28683268)
1. Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions.
Shrivastava AN; Aperia A; Melki R; Triller A
Neuron; 2017 Jul; 95(1):33-50. PubMed ID: 28683268
[TBL] [Abstract][Full Text] [Related]
2. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
3. Protein transmission in neurodegenerative disease.
Peng C; Trojanowski JQ; Lee VM
Nat Rev Neurol; 2020 Apr; 16(4):199-212. PubMed ID: 32203399
[TBL] [Abstract][Full Text] [Related]
4. What is strain in neurodegenerative diseases?
Tian Y; Meng L; Zhang Z
Cell Mol Life Sci; 2020 Feb; 77(4):665-676. PubMed ID: 31531680
[TBL] [Abstract][Full Text] [Related]
5. Application of yeast to studying amyloid and prion diseases.
Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
[TBL] [Abstract][Full Text] [Related]
6. [The role of proteins in neurodegenerative disease].
Szwed A; Miłowska K
Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103
[TBL] [Abstract][Full Text] [Related]
7. Prions: generation and spread versus neurotoxicity.
Halliday M; Radford H; Mallucci GR
J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
[TBL] [Abstract][Full Text] [Related]
8. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
Nguyen PH; Ramamoorthy A; Sahoo BR; Zheng J; Faller P; Straub JE; Dominguez L; Shea JE; Dokholyan NV; De Simone A; Ma B; Nussinov R; Najafi S; Ngo ST; Loquet A; Chiricotto M; Ganguly P; McCarty J; Li MS; Hall C; Wang Y; Miller Y; Melchionna S; Habenstein B; Timr S; Chen J; Hnath B; Strodel B; Kayed R; Lesné S; Wei G; Sterpone F; Doig AJ; Derreumaux P
Chem Rev; 2021 Feb; 121(4):2545-2647. PubMed ID: 33543942
[TBL] [Abstract][Full Text] [Related]
9. Visualization of prion-like transfer in Huntington's disease models.
Jansen AH; Batenburg KL; Pecho-Vrieseling E; Reits EA
Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):793-800. PubMed ID: 28040507
[TBL] [Abstract][Full Text] [Related]
10. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.
Choonara YE; Pillay V; Du Toit LC; Modi G; Naidoo D; Ndesendo VMK; Sibambo SR
Int J Mol Sci; 2009 Jun; 10(6):2510-2557. PubMed ID: 19582217
[TBL] [Abstract][Full Text] [Related]
11. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
12. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.
Melki R
J Parkinsons Dis; 2015; 5(2):217-27. PubMed ID: 25757830
[TBL] [Abstract][Full Text] [Related]
13. Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.
Allison WT; DuVal MG; Nguyen-Phuoc K; Leighton PLA
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064456
[TBL] [Abstract][Full Text] [Related]
14. Neurodegeneration. Could they all be prion diseases?
Miller G
Science; 2009 Dec; 326(5958):1337-9. PubMed ID: 19965731
[No Abstract] [Full Text] [Related]
15. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
16. [Conformationally altered proteins cause neurodegenerative diseases].
Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
[TBL] [Abstract][Full Text] [Related]
17. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
Marrero-Winkens C; Sankaran C; Schätzl HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.
Jucker M; Walker LC
Ann Neurol; 2011 Oct; 70(4):532-40. PubMed ID: 22028219
[TBL] [Abstract][Full Text] [Related]
19. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
20. Protein folding diseases and neurodegeneration: lessons learned from yeast.
Winderickx J; Delay C; De Vos A; Klinger H; Pellens K; Vanhelmont T; Van Leuven F; Zabrocki P
Biochim Biophys Acta; 2008 Jul; 1783(7):1381-95. PubMed ID: 18298958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
